Safety of Rivipansel (GMI-1070) in the Treatment of One or More Vaso-Occlusive Crises in Hospitalized Subjects With Sickle Cell Disease

Clinical trial NCT02433158 · TERMINATED

Trial details

NCT number: NCT02433158
Sponsor: GlycoMimetics Incorporated
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Sickle Cell Anemia Sickle Cell Disease Sickle Cell Disorders Pain Crisis Vaso-occlusive Crisis

Start date: 2015-12-16
Primary completion: 2019-11-15
Enrollment: 154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.